An Acadia Pharmaceuticals Insider Sold Nearly Half Their Shares in the Company. What Does That Mean for Investors?
| | | |

An Acadia Pharmaceuticals Insider Sold Nearly Half Their Shares in the Company. What Does That Mean for Investors?

James Kihara, Principal Accounting Officer of Acadia Pharmaceuticals (NASDAQ:ACAD), disclosed the sale of 11,421 shares of common stock in an open-market transaction on June 26, 2026, according to the SEC Form 4 filing. Transaction summary Transaction value based on SEC Form 4 weighted average price ($26.08); post-transaction value based on June 26, 2026 market close…

Vertex Pharmaceuticals Bets  Billion on Crinetics to Build Endocrinology Powerhouse
| | | |

Vertex Pharmaceuticals Bets $10 Billion on Crinetics to Build Endocrinology Powerhouse

Key Points Interested in Vertex Pharmaceuticals Incorporated? Here are five stocks we like better. Vertex Pharmaceuticals agreed to buy Crinetics Pharmaceuticals for $85 per share in cash, valuing the deal at about $10 billion equity value ($8.8 billion net of cash). Vertex says the acquisition is a strategic move to build an endocrinology franchise and…

Bitcoin dropped 2% then rebounded after Trump said he’s ‘a big crypto guy’ — here are experts takes on buying the dip
| | | |

Bitcoin dropped 2% then rebounded after Trump said he’s ‘a big crypto guy’ — here are experts takes on buying the dip

On July 6, Bitcoin dropped more than 2% after Strategy — a corporate buyer of Bitcoin — disclosed in a regulatory filing (1) that it had sold about $216 million worth of the cryptocurrency. That’s the second time this year the company has sold some of its Bitcoin reserves — a complete reversal of its…

Can Colombia’s New Government Reverse the Nation’s Oil and Gas Decline?
| | | |

Can Colombia’s New Government Reverse the Nation’s Oil and Gas Decline?

In a closely contested presidential election in Colombia, controversial far-right candidate Abelardo de la Espriella emerged victorious. After an official recount, his opponent, left-wing senator Ivan Cepeda, conceded defeat. This was a hard-fought campaign which split the community, sparking much controversy across Colombia. While debate rages over De la Espriella’s policies and ascension to power,…

After saving on their own, retirees are turning to financial advisers ‘to know if they are on track’
| | | |

After saving on their own, retirees are turning to financial advisers ‘to know if they are on track’

Retirees are turning to financial advisers, many for the first time, after navigating their saving years on their own.  About a quarter of retirees who have never worked with a financial adviser are now on board, double the number from five years ago. “Retirees increasingly have lump sum savings from retirement plans that they need…

OpenAI and Anthropic warn China is using tens of thousands of fake accounts to copy their AI models
| | | |

OpenAI and Anthropic warn China is using tens of thousands of fake accounts to copy their AI models

As much as U.S. President Donald Trump and Chinese Paramount Leader Xi Jinping work to ease historical tensions (1), our two nations remain locked in a perpetual neck-and-neck power struggle in a number of arenas (2), AI being chief among them. But, to some, it seems like China may be playing dirty when it comes…

Elon Musk Admits He Was ‘Clearly Wrong’ About Anthropic— and Promises Not to Weaponize SpaceXAI’s Compute Access Against the Claude Maker: ‘Not My Style’
| | | |

Elon Musk Admits He Was ‘Clearly Wrong’ About Anthropic— and Promises Not to Weaponize SpaceXAI’s Compute Access Against the Claude Maker: ‘Not My Style’

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Elon Musk publicly reversed his earlier view of Anthropic on Thursday, saying he was “clearly wrong” to doubt the AI company and pledging not to use SpaceXAI’s compute leverage to harm a competitor. Musk Calls Anthropic Current AI…

‘Market is becoming more discerning’: Wall Street weighs next catalyst for AI trade
| | | |

‘Market is becoming more discerning’: Wall Street weighs next catalyst for AI trade

Wall Street is looking for follow-through on the AI trade heading into earnings season next week. The S&P 500 (GSPC) gained less than 1% last week. The Nasdaq (IXIC) whipsawed back and forth, with semiconductors at the center of that trade. “The moves have been probably pretty frenetic,” T. Rowe Price portfolio manager Tony Wang…

How To Earn 0 A Month From Wells Fargo Stock Ahead Of Q2 Earnings
| | | |

How To Earn $500 A Month From Wells Fargo Stock Ahead Of Q2 Earnings

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Wells Fargo & Company will release earnings for its second quarter before the opening bell on Tuesday, July 14. Analysts expect the bank to report quarterly earnings of $1.71 per share. That’s up from $1.60 per share in…

End of content

End of content